Skip to content

Factors Affecting Survival in severe and very severe copd patients admitted in Tertiary care centers.

Clinical and microbiological predictors of survival in severe and very severe COPD after admission in tertiary care centers of Mysore, India- A multicentric longitudinal cohort study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054372
Enrollment
1000
Registered
2023-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

None listed

Sponsors

Sumalatha A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)COPD subjects with either a history of smoking of >10 Pack Years or biomass exposure of >60 Biomass index. 2)There should be objective evidence of COPD diagnosis by means as suggested by GOLD criteria with a ratio of FEV1/FVC of less than 70%. 3)Acute exacerbation of COPD requiring hospital admission for > 48 hours. 4)COPD patients with severe and very severe disease as per GOLD stages 3 and 4.

Exclusion criteria

Exclusion criteria: 1)Absence of an adequate sputum specimen as determined by gram stain. 2)Patients with chronic pulmonary disorders other than COPD. 3)Lack of consent. 4)Lack of cooperation for nutritional or mental health assessment.

Design outcomes

Primary

MeasureTime frame
MORTALITY, ICU MORTALITY, IN HOSPITAL MORTALITY, SurvivalTimepoint: 2 YEARS

Secondary

MeasureTime frame
1.Phenotype identification 2.Comparison between obese and malnourished copd. 3.Comparison between tobacco and biomass copd.Timepoint: 2 years

Countries

India

Contacts

Public ContactSumalatha A

JSS medical college and Research Institue, Mysuru.

mahesh1971in@yahoo.com9448044003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026